Abizer Gaslightwala - Jun 20, 2025 Form 4 Insider Report for Akari Therapeutics Plc (AKTX)

Role
President & CEO, Director
Signature
/s/ Torsten Hombeck, as Attorney-in-Fact
Stock symbol
AKTX
Transactions as of
Jun 20, 2025
Transactions value $
$12,000
Form type
4
Date filed
6/24/2025, 04:30 PM
Previous filing
Jun 20, 2025
Next filing
Jun 25, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Gaslightwala Abizer President & CEO, Director C/O AKARI THERAPEUTICS PLC, 22 BOSTON WHARF ROAD FL 7, BOSTON /s/ Torsten Hombeck, as Attorney-in-Fact 2025-06-24 0002049375

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKTX American Depositary Shares representing Ordinary Shares Purchase $12K +10K +3.83% $1.20 271K Jun 20, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.